Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure

por Griffiths, Christopher E. M., Gooderham, Melinda, Colombel, Jean-Frederic, Terui, Tadashi, Accioly, Ana P., Gallo, Gaia, Zhu, Danting, Blauvelt, Andrew
Publicado 2022

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

por Deodhar, Atul A, Combe, Bernard, Accioly, Ana P, Bolce, Rebecca, Zhu, Danting, Gellett, Amanda M, Sprabery, Aubrey Trevelin, Burmester, Gerd-Rüdiger R
Publicado 2022